Quest Diagnostics Updates Outlook for Investor Day

 - Company to repurchase $900 million of its shares in first half of 2021

- Long-term outlook 2022-24 compound annual growth rate (CAGR): Base business revenues (which excludes COVID-19 testing) expected to grow 4-5% and adjusted diluted earnings per share (EPS) for the total company expected to grow 7-9%

- Invigorate savings of 3% annually expected to continue

- COVID-19 testing is expected to continue into 2022 at lower levels as it moves from primarily clinical uses to testing in support of "Return-to-Life" activities

- Outlook for first half of 2021 remains unchanged

The Company's outlook for the first half of 2021 remains unchanged as follows:

	Low		High
Net revenues	$4.85 billion		$5.15 billion
Net revenues increase	32.9%		41.1%
Reported diluted EPS	$5.07		$6.07
Adjusted diluted EPS	$5.90		$6.90
Cash provided by operations	At least $800 million
Capital expenditures	Approximately $200 million
						The virtual event will begin at 9:00 am ET.  To access the live webcast, including audio, video and presentation slides, interested parties must register in advance here. Securities analysts and institutional investors are advised to register in advance. Investors and analysts who register will have an opportunity to ask questions in live Q&A sessions with speakers. Participants who would like to ask a question can dial 888-455-0391 within the U.S. and Canada, or (773) 756-0467 internationally, using the passcode "7895081." Interested parties unable to watch the live webcast will be able to view and listen to an archived copy of the webcast, which will be available on the Quest Diagnostics Investor Relations website following the conclusion of the event.  Anyone listening to the webcast is encouraged to read the company's periodic reports, on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports. https://www.prnewswire.com/news-releases/quest-diagnostics-updates-strategic-growth-drivers-and-provides-long-term-outlook-at-2021-virtual-investor-day-301245147.html